Furthermore, we identified the top 100 proteogenomic DE markers in each RCC subtype (Figure S2I; Table S3) and noted their distinct enrichment among benign nephron cell types (Figure 2D), for example MAPRE3 in RO and PIGR in pRCC, which are described in later sections. The gene discussed is MAPRE3; the disease is renal cell carcinoma.